| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/03/2001 | CA2118043C Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 04/03/2001 | CA2093422F Detergent compositions containing cellulase compositions deficient in cbh i type components |
| 04/03/2001 | CA2066234C Activation compounds and methods for nucleic acid sterilization |
| 04/03/2001 | CA2041728C Method for the prevention of crop injury in the presence of synergistic pesticide combinations |
| 04/01/2001 | CA2319853A1 Floral homeotic genes for manipulation of flowering in poplar trees and other plant species |
| 04/01/2001 | CA2319168A1 Hyperactive mutants of himar1 transposase and methods for using the same |
| 04/01/2001 | CA2284246A1 Plant fatty acid desaturases and alleles therefor |
| 03/30/2001 | WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
| 03/30/2001 | WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 03/30/2001 | WO2002090588A1 Interfering with telomere maintenance in treatment of diseases |
| 03/30/2001 | CA2385808A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
| 03/30/2001 | CA2384139A1 Interfering with telomere maintenance in treatment of diseases |
| 03/30/2001 | CA2303038A1 Non-human animal mutants and methods for production of the same |
| 03/30/2001 | CA2283538A1 New hev antigenic peptide and methods |
| 03/29/2001 | WO2001022092A2 Method to identify compounds which modulate fra-1 expression fils |
| 03/29/2001 | WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | WO2001022083A2 Method for identifying mhc-restricted antigens |
| 03/29/2001 | WO2001021838A2 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/29/2001 | WO2001021837A1 Methods for potentiating antisense rna techniques |
| 03/29/2001 | WO2001021831A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | WO2001021830A1 Nuclease inhibitor cocktail |
| 03/29/2001 | WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | WO2001021825A2 Novel enzymes which dehydrate glycerol |
| 03/29/2001 | WO2001021824A1 Helper vectors and cell lines for the production of pseudoadenoviral vectors |
| 03/29/2001 | WO2001021823A2 Adenoviral vector with a reporter gene linked to a regulatory region |
| 03/29/2001 | WO2001021822A1 Methods and means for modification of plant flowering characteristics |
| 03/29/2001 | WO2001021821A2 Insect-resistant rice plants |
| 03/29/2001 | WO2001021820A1 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene |
| 03/29/2001 | WO2001021819A2 Method for genetic modification of lactobacillus delbrueckii |
| 03/29/2001 | WO2001021818A1 Lactobacillus delbruckii strain and its use for screening plasmids |
| 03/29/2001 | WO2001021817A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | WO2001021816A1 MODULATION OF IgE RECEPTOR CELL SURFACE EXPRESSION |
| 03/29/2001 | WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021814A1 Heparanase-2, a member of the heparanase protein family |
| 03/29/2001 | WO2001021813A1 Method and compositions for improved polynucleotide synthesis |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021811A1 Dna immunization against chlamydia infection |
| 03/29/2001 | WO2001021810A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021809A2 Stachybotrys phenol oxidizing enzyme |
| 03/29/2001 | WO2001021807A1 Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| 03/29/2001 | WO2001021806A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021805A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021803A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021802A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021801A1 Gene treatment to enhance feed efficiency and growth rate of livestock |
| 03/29/2001 | WO2001021800A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus) |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021798A2 Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof |
| 03/29/2001 | WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021795A2 Fatty acid transport proteins |
| 03/29/2001 | WO2001021794A2 Smad associating polypeptides |
| 03/29/2001 | WO2001021793A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 03/29/2001 | WO2001021792A1 Transporter genes oatp-b, c, d and e |
| 03/29/2001 | WO2001021791A2 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides |
| 03/29/2001 | WO2001021790A1 Conditional immortalisation of cells |
| 03/29/2001 | WO2001021789A1 Ribozymes used for restenosis prevention |
| 03/29/2001 | WO2001021788A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 03/29/2001 | WO2001021785A2 Megagametophyte transcriptional control elements and uses thereof |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021783A2 Seed-preferred promoter from maize |
| 03/29/2001 | WO2001021782A2 Enhancer elements for increased translation in plant plastids |
| 03/29/2001 | WO2001021781A2 Methods for site-associated modification of gene activity and nucleic acid structure |
| 03/29/2001 | WO2001021780A2 Targeted gene removal |
| 03/29/2001 | WO2001021776A1 A NOVEL TYPE II RESTRICTION ENDONUCLEASE, HpyCH4V, OBTAINABLE FROM HELICOBACTER PYLORI CH4 AND A PROCESS FOR PRODUCING THE SAME |
| 03/29/2001 | WO2001021775A1 Gene encoding novel human secretory phospholipase a¿2? |
| 03/29/2001 | WO2001021774A1 Novel transaldolase gene |
| 03/29/2001 | WO2001021773A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021772A2 Methods and microorganisms for production of panto-compounds |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021770A2 Gst sequences from soybean and their use in the production of herbicide resistant plants |
| 03/29/2001 | WO2001021768A1 Site-specific recombination system to manipulate the plastid genome of higher plants |
| 03/29/2001 | WO2001021764A1 A pcra helicase of staphylococcus aureus |
| 03/29/2001 | WO2001021761A2 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 03/29/2001 | WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021657A1 Novel protein, gene encoding the same and method of utilization thereof |
| 03/29/2001 | WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021651A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021650A2 Cis-prenyltransferases from plants |
| 03/29/2001 | WO2001021644A2 Wheat dp proteins and uses thereof |
| 03/29/2001 | WO2001021641A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 03/29/2001 | WO2001021632A1 Method for nucleic acid isolation and kit |
| 03/29/2001 | WO2001021310A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 03/29/2001 | WO2001021270A2 Methods for producing recombinant proteins |
| 03/29/2001 | WO2001021216A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021205A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021201A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 03/29/2001 | WO2001021200A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | WO2001021199A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 03/29/2001 | WO2001021184A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | WO2001020974A1 Quantitative transient protein expression in plant tissue culture |
| 03/29/2001 | WO2001020973A2 Plant genes for sensitivity to ethylene and pathogens |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |